CAHILL BRIAN JOSEPH (Chief Financial Officer) reported 1 transaction at EAGLE PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 1/9/2024ACC: 0001209191-24-001256
Officer· Chief Financial Officer
Since Oct 2020
-735.00
Net shares
Net seller
$3.8K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
735.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−735.00
Price / share
$5.13
Trade value
$3.77K
% of position
1.6%
1/5/2024
47.42K→46.68K
Total
Net shares
−735.00
Net value
-$3.77K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/5/2024 | F · Tax Withholding | −735.00 | $5.13 | $3.77K | 1.6% | 47.42K | 46.68K |
| Total | −735.00 | -$3.77K | ||||||
Derivative Transactions0
No derivative transactions reported